PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: chloe.bloom06@imperial.ac.uk.\', \'Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.\', \'Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Dundee, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK.\', \'Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK.\', \'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'National Heart and Lung Institute, Imperial College London, London, UK; National Infection Service, Public Health England, London, UK.\', \'Roslin Institute, University of Edinburgh, Edinburgh, UK.\', \'Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK; Department of Respiratory Medicine, Alder Hey Children\'s Hospital, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2213-2600(21)00013-810.1016/S2213-2600(21)00013-8
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 33676593
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all